Patient attitudes and preferences about expanded noninvasive prenatal testing

被引:11
作者
Dubois, Marie-Line [1 ]
Winters, Patricia D. [2 ]
Rodrigue, Marc-Andre [3 ]
Gekas, Jean [1 ,3 ]
机构
[1] Laval Univ, Fac Med, Quebec City, PQ, Canada
[2] Illumina Inc, San Diego, CA USA
[3] Laval Univ, Univ Hosp Quebec, CHU Quebec Res & Mother & Child Ctr, Dept Med Genet, Quebec City, PQ, Canada
关键词
noninvasive prenatal testing; cell-free DNA; patient preference; surveys and questionnaires; aneuploidy; informed consent; incidental findings; FETAL ANEUPLOIDY; PREGNANT-WOMEN; VIEWS; ABNORMALITIES; MICRODELETION; PERSPECTIVES; ULTRASOUND; ANOMALIES; STATEMENT; IMPACT;
D O I
10.3389/fgene.2023.976051
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Noninvasive prenatal testing (NIPT) using cell-free DNA (cfDNA) is typically carried out to screen for common fetal chromosomal anomalies, with the option to screen for a wider range of chromosomal changes (expanded NIPT) becoming increasingly available. However, little is known about pregnant patients' attitudes and preferences regarding expanded NIPT.Methods: To address this gap, we surveyed general-risk patients having first-tier cfDNA screening at a private prenatal clinic on their expectations for expanded NIPT. Patients were asked questions regarding their current pregnancy and previous pregnancy history, their opinions on fetal DNA screenings during pregnancy and incidental findings, information and opinions on financial resources for NIPT, as well as socio-cultural questions to determine patient demographics.Results: Of the 200 survey participants, the majority were educated, self-reported as white, had a higher than average income, and reported no aneuploidy risk factors. When asked what information they would like to receive from cfDNA screening, the vast majority of participants wanted all information available that could have an immediate impact on fetal health (88%) or an immediate impact on infant health from birth (82%). Many participants also wanted information that could have a future impact on the child's health or an immediate or future impact on the pregnant woman's own health. Most participants wanted information about the sex of fetus (86%) and common trisomies (71%), with almost half of participants desiring information about rare autosomal aneuploidies and/or all genetic information that may affect the baby. In addition, participants were found to be comfortable screening for conditions that are well-known, influence care during pregnancy, and are treatable. Finally, while most respondents either had insurance coverage for NIPT or were able to afford NIPT out of pocket, the majority of our participants felt that expanded NIPT should be either free for everyone or for those considered high risk.Discussion: Our findings suggest that with appropriate pre-test counseling, pregnant patients may choose NIPT for an expanding list of conditions.
引用
收藏
页数:12
相关论文
共 50 条
[1]  
Abdo N, 2018, EPIGENETICS INSIGHTS, V11, DOI [10.1177/2516865718813122, 10.1177/2516865118813122]
[2]   A first look at women's perspectives on noninvasive prenatal testing to detect sex chromosome aneuploidies and microdeletion syndromes [J].
Agatisa, Patricia K. ;
Mercer, Mary Beth ;
Leek, Angela C. ;
Smith, Marissa B. ;
Philipson, Elliot ;
Farrell, Ruth M. .
PRENATAL DIAGNOSIS, 2015, 35 (07) :692-698
[3]  
Audibert F, 2017, J OBSTET GYNAECOL CA, V39, P805, DOI 10.1016/j.jogc.2017.01.032
[4]   Evaluating Expanded Noninvasive Prenatal Screening [J].
Bayefsky, Michelle J. ;
Caplan, Arthur L. ;
Hoskins, Iffath A. .
OBSTETRICS AND GYNECOLOGY, 2022, 139 (06) :1009-1011
[5]   Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers [J].
Benachi, Alexandra ;
Caffrey, Jessica ;
Calda, Pavel ;
Carreras, Elena ;
Jani, Jacques C. ;
Kilby, Mark D. ;
Klein, Hanns-Georg ;
Rizzo, Giuseppe ;
Yaron, Yuval .
EUROPEAN JOURNAL OF MEDICAL GENETICS, 2020, 63 (01)
[6]   Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis [J].
Benn, Peter ;
Borrell, Antoni ;
Chiu, Rossa W. K. ;
Cuckle, Howard ;
Dugoff, Lorraine ;
Faas, Brigitte ;
Gross, Susan ;
Huang, Tianhua ;
Johnson, Joann ;
Maymon, Ron ;
Norton, Mary ;
Odibo, Anthony ;
Schielen, Peter ;
Spencer, Kevin ;
Wright, Dave ;
Yaron, Yuval .
PRENATAL DIAGNOSIS, 2015, 35 (08) :725-734
[7]  
BeSHG, 2017, NIPT GOOD CLIN PRACT
[8]  
BeSHG, 2020, BELG GUID MAN INC FI
[9]   The implementation of non-invasive prenatal testing (NIPT) in the Netherlands [J].
Bilardo, Caterina M. .
JOURNAL OF PERINATAL MEDICINE, 2021, 49 (08) :941-944
[10]   The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access [J].
Birko, Stanislav ;
Ravitsky, Vardit ;
Dupras, Charles ;
Le Clerc-Blain, Jessica ;
Lemoine, Marie-Eve ;
Affdal, Aliya O. ;
Haidar, Hazar ;
Laberge, Anne-Marie .
BMC PREGNANCY AND CHILDBIRTH, 2019, 19 (1)